Skip to main content

Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review

  • Kenneth R. Kaufman (a1), Melissa Coluccio (a2), Kartik Sivaraaman (a3) and Miriam Campeas (a2)

Optimal anti-epileptic drug (AED) treatment maximises therapeutic response and minimises adverse effects (AEs). Key to therapeutic AED treatment is adherence. Non-adherence is often related to severity of AEs. Frequently, patients do not spontaneously report, and clinicians do not specifically query, critical AEs that lead to non-adherence, including sexual dysfunction. Sexual dysfunction prevalence in patients with epilepsy ranges from 40 to 70%, often related to AEDs, epilepsy or mood states. This case reports lamotrigine-induced sexual dysfunction leading to periodic non-adherence.


To report lamotrigine-induced sexual dysfunction leading to periodic lamotrigine non-adherence in the context of multiple comorbidities and concurrent antidepressant and antihypertensive pharmacotherapy.


Case analysis with PubMed literature review.


A 56-year-old male patient with major depression, panic disorder without agoraphobia and post-traumatic stress disorder was well-controlled with escitalopram 20 mg bid, mirtazapine 22.5 mg qhs and alprazolam 1 mg tid prn. Comorbid conditions included complex partial seizures, psychogenic non-epileptic seizures (PNES), hypertension, gastroesophageal reflux disease and hydrocephalus with patent ventriculoperitoneal shunt that were effectively treated with lamotrigine 100 mg tid, enalapril 20 mg qam and lansoprazole 30 mg qam. He acknowledged non-adherence with lamotrigine secondary to sexual dysfunction. With lamotrigine 300 mg total daily dose, he described no libido with impotence/anejaculation/anorgasmia. When off lamotrigine for 48 h, he described becoming libidinous with decreased erectile dysfunction but persistent anejaculation/anorgasmia. When off lamotrigine for 72 h to maximise sexual functioning, he developed auras. Family confirmed patient's consistent monthly non-adherence for 2–3 days during the past year.


Sexual dysfunction is a key AE leading to AED non-adherence. This case describes dose-dependent lamotrigine-induced sexual dysfunction with episodic non-adherence for 12 months. Patient/clinician education regarding AED-induced sexual dysfunction is warranted as are routine sexual histories to ensure adherence.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
      Available formats
This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) license.
Corresponding author
Kenneth R. Kaufman, Departments of Psychiatry, Neurology and Anesthesiology, Rutgers Robert Wood Johnson Medical School, 125 Paterson Street, Suite #2200, New Brunswick, NJ 08901, USA.
Hide All

Presented in part at the 19th Annual Conference of the International Society of Bipolar Disorders, Washington DC, 4–7 May 2017.

Declaration of interest

No financial interests. K.R.K. is Editor of BJPsych Open; he took no part in the peer-review of this work.

Hide All
1 Boon, P, Engelborghs, S, Hauman, H, Jansen, A, Lagae, L, Legros, B, et al. Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: an update. Acta Neurol Belg 2012; 112: 119–31.
2 Ketter, TA, Miller, S, Dell’Osso, B, Calabrese, JR, Frye, MA, Citrome, L. Balancing benefits and harms of treatments for acute bipolar depression. J Affect Disord 2014; 169 (suppl 1): S2433.
3 Buelow, JM, Smith, MC. Medication management by the person with epilepsy: perception versus reality. Epilepsy Behav 2004; 5: 401–6.
4 Chapman, SC, Horne, R, Chater, A, Hukins, D, Smithson, WH. Patients’ perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav 2014; 31: 312–20.
5 Sajatovic, M, Valenstein, M, Blow, F, Ganoczy, D, Ignacio, R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv 2007; 58: 855–63.
6 Ettinger, AB, Manjunath, R, Candrilli, SD, Davis, KL. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 2009; 14: 324–9.
7 Olesen, J, Gustavsson, A, Svensson, M, Wittchen, HU, Jönsson, B, CDBE2010 Study Group et al. The economic cost of brain disorders in Europe. Eur J Neurol 2012; 19: 155–62.
8 Whiteford, HA, Ferrari, AJ, Degenhardt, L, Feigin, V, Vos, T. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. PLoS One 2015; 10: e0116820.
9 Kessler, RC, Akiskal, HS, Ames, M, Birnbaum, H, Greenberg, P, Hirschfeld, RM, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry 2006; 163: 1561–8.
10 Getnet, A, Woldeyohannes, SM, Bekana, L, Mekonen, T, Fekadu, W, Menberu, M, et al. Antiepileptic drug nonadherence and its predictors among people with epilepsy. Behav Neurol 2016; 2016: 3189108.
11 Nakhutina, L, Gonzalez, JS, Margolis, SA, Spada, A, Grant, A. Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav 2011; 22: 584–6.
12 Baldessarini, RJ, Perry, R, Pike, J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol 2008; 23: 95105.
13 Leclerc, E, Mansur, RB, Brietzke, E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord 2013; 149: 247–52.
14 Mitchell, AJ, Selmes, T. Why don't patients take their medicine? Reasons and solutions in psychiatry. Adv Psychiatr Treat 2007; 13: 336–46.
15 Sleath, B, Rubin, RH, Huston, SA. Hispanic ethnicity, physician-patient communication, and antidepressant adherence. Compr Psychiatry 2003; 44: 198204.
16 Serretti, A, Chiesa, A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol 2009; 29: 259–66.
17 Kaufman, KR, Wong, S, Sivaraaman, K, Anim, C, Delatte, D. Epilepsy and AED-induced decreased libido – the unasked psychosocial comorbidity. Epilepsy Behav 2015; 52(Pt A): 236–8.
18 Henning, OJ, Nakken, KO, Træen, B, Mowinckel, P, Lossius, M. Sexual problems in people with refractory epilepsy. Epilepsy Behav 2016; 61: 174–9.
19 Sivaraaman, K, Mintzer, S. Hormonal consequences of epilepsy and its treatment in men. Curr Opin Endocrinol Diabetes Obes 2011; 18: 204–9.
20 Michael, A, O’Keane, V. Sexual dysfunction in depression. Hum Psychopharmacol 2000; 15: 337–45.
21 Grover, S, Ghosh, A, Sarkar, S, Chakrabarti, S, Avasthi, A. Sexual dysfunction in clinically stable patients with bipolar disorder receiving lithium. J Clin Psychopharmacol 2014; 34: 475–82.
22 La Torre, A, Giupponi, G, Duffy, DM, Pompili, M, Grözinger, M, Kapfhammer, HP, et al. Sexual dysfunction related to psychotropic drugs: a critical review. Part III: mood stabilizers and anxiolytic drugs. Pharmacopsychiatry 2014; 47: 16.
23 Kaufman, KR, Struck, PJ. Gabapentin-induced sexual dysfunction. Epilepsy Behav 2011; 21: 324–6.
24 Kandeel, FR, Koussa, VK, Swerdloff, RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev 2001; 22: 342–88.
25 Capogrosso, P, Ventimiglia, E, Boeri, L, Capitanio, U, Gandaglia, G, Dehò, F, et al. Sexual functioning mirrors overall men's health status, even irrespective of cardiovascular risk factors. Andrology 2017; 5: 63–9.
26 Viigimaa, M, Doumas, M, Vlachopoulos, C, Anyfanti, P, Wolf, J, Narkiewicz, K, et al. Hypertension and sexual dysfunction: time to act. J Hypertens 2011; 29: 403–7.
27 Francis, ME, Kusek, JW, Nyberg, LM, Eggers, PW. The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males. J Urol 2007; 178: 591–6.
28 McCabe, MP, Sharlip, ID, Lewis, R, Atalla, E, Balon, R, Fisher, AD, et al. Risk factors for sexual dysfunction among women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016; 13: 153–67.
29 Lehrner, A, Flory, JD, Bierer, LM, Makotkine, I, Marmar, CR, Yehuda, R. Sexual dysfunction and neuroendocrine correlates of posttraumatic stress disorder in combat veterans: preliminary findings. Psychoneuroendocrinology 2016; 63: 271–5.
30 Kumsar, NA, Kumsar, Ş, Dilbaz, N. Sexual dysfunction in men diagnosed as substance use disorder. Andrologia 2016; 48: 1229–35.
31 Naranjo, CA, Shear, NH, Lanctôt, KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol 1992; 32: 897904.
32 Kennedy, SH, Dugré, H, Defoy, I. A multicenter, double-blind, placebo-controlled study of sildenafil citrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of major depressive disorder. Int Clin Psychopharmacol 2011; 26: 151–8.
33 Seidman, S. Ejaculatory dysfunction and depression: pharmacological and psychobiological interactions. Int J Impot Res 2006; 18 (suppl 1): S338.
34 Rajkumar, RP, Kumaran, AK. Depression and anxiety in men with sexual dysfunction: a retrospective study. Compr Psychiatry 2015; 60: 114–8.
35 Blumentals, WA, Gomez-Caminero, A, Brown, RR, Vannappagari, V, Russo, LJ. A case-control study of erectile dysfunction among men diagnosed with panic disorder. Int J Impot Res 2004; 16: 299302.
36 Badour, CL, Gros, DF, Szafranski, DD, Acierno, R. Problems in sexual functioning among male OEF/OIF veterans seeking treatment for posttraumatic stress. Compr Psychiatry 2015; 58: 7481.
37 Smaldone, M, Sukkarieh, T, Reda, A, Khan, A. Epilepsy and erectile dysfunction: a review. Seizure 2004; 13: 453–9.
38 Hellmis, E. Sexual problems in males with epilepsy – an interdisciplinary challenge! Seizure 2008; 17: 136–40.
39 Aull-Watschinger, S, Pataraia, E, Baumgartner, C. Sexual auras: predominance of epileptic activity within the mesial temporal lobe. Epilepsy Behav 2008; 12: 124–7.
40 Suffren, S, Braun, CM, Guimond, A, Devinsky, O. Opposed hemispheric specializations for human hypersexuality and orgasm? Epilepsy Behav 2011; 21: 12–9.
41 Fiszman, A, Alves-Leon, SV, Nunes, RG, D’Andrea, I, Figueira, I. Traumatic events and posttraumatic stress disorder in patients with psychogenic nonepileptic seizures: a critical review. Epilepsy Behav 2004; 5: 818–25.
42 Baslet, G, Roiko, A, Prensky, E. Heterogeneity in psychogenic nonepileptic seizures: understanding the role of psychiatric and neurological factors. Epilepsy Behav 2010; 17: 236–41.
43 Doumas, M, Douma, S. Sexual dysfunction in essential hypertension: myth or reality? J Clin Hypertens (Greenwich) 2006; 8: 269–74.
44 Iovino, P, Pascariello, A, Limongelli, P, Tremolaterra, F, Consalvo, D, Sabbatini, F, et al. The prevalence of sexual behavior disorders in patients with treated and untreated gastroesophageal reflux disease. Surg Endosc 2007; 21: 1104–10.
45 Missori, P, Scollato, A, Formisano, R, Currà, A, Mina, C, Marianetti, M, et al. Restoration of sexual activity in patients with chronic hydrocephalus after shunt placement. Acta Neurochir (Wien) 2009; 151: 1241–4.
46 La Torre, A, Giupponi, G, Duffy, D, Conca, A. Sexual dysfunction related to psychotropic drugs: a critical review – part I: antidepressants. Pharmacopsychiatry 2013; 46: 191–9.
47 Montejo, AL, Llorca, G, Izquierdo, JA, Rico-Villademoros, F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001; 62 (suppl 3): 1021.
48 Fossey, MD, Hamner, MB. Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety 1994–1995; 1: 233–6.
49 Uhde, TW, Tancer, ME, Shea, CA. Sexual dysfunction related to alprazolam treatment of social phobia. Am J Psychiatry 1988; 145: 531–2.
50 Kaufman, KR. Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy Behav 2011; 21: 111.
51 Calabrò, RS, Italiano, D, Militi, D, Bramanti, P. Levetiracetam-associated loss of libido and anhedonia. Epilepsy Behav 2012; 24: 283–4.
52 Herzog, AG, Drislane, FW, Schomer, DL, Pennell, PB, Bromfield, EB, Dworetzky, BA, et al. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 2005; 65: 1016–20.
53 Gil-Nagel, A, López-Muñoz, F, Serratosa, JM, Moncada, I, García-García, P, Alamo, C. Effect of lamotrigine on sexual function in patients with epilepsy. Seizure 2006; 15: 142–9.
54 Svalheim, S, Taubøll, E, Luef, G, Lossius, A, Rauchenzauner, M, Sandvand, F, et al. Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults. Epilepsy Behav 2009; 16: 281–7.
55 Husain, AM, Carwile, ST, Miller, PP, Radtke, RA. Improved sexual function in three men taking lamotrigine for epilepsy. South Med J. 2000; 93: 335–6.
56 Grimm, RH Jr, Grandits, GA, Prineas, RJ, McDonald, RH, Lewis, CE, Flack, JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29(Pt 1): 814.
57 La Torre, A, Giupponi, G, Duffy, D, Conca, A, Catanzariti, D. Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs. Pharmacopsychiatry 2015; 48: 16.
58 Brixius, K, Middeke, M, Lichtenthal, A, Jahn, E, Schwinger, RH. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol 2007; 34: 327–31.
59 Fogari, R, Zoppi, A. Effects of antihypertensive therapy on sexual activity in hypertensive men. Curr Hypertens Rep 2002; 4: 202–10.
60 Coulson, M, Gibson, GG, Plant, N, Hammond, T, Graham, M. Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis. Toxicol Appl Pharmacol 2003; 192: 154–63.
61 Lindquist, M, Edwards, IR. Endocrine adverse effects of omeprazole. BMJ 1992; 305: 451–2.
62 Lareb. Omeprazole and Erectile Dysfunction (
63 Cascorbi, I. Drug interactions – principles, examples and clinical consequences. Dtsch Arztebl Int 2012; 109: 546–56.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Open
  • ISSN: -
  • EISSN: 2056-4724
  • URL: /core/journals/bjpsych-open
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review

  • Kenneth R. Kaufman (a1), Melissa Coluccio (a2), Kartik Sivaraaman (a3) and Miriam Campeas (a2)
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *